SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Geron Corp.
GERN 1.545+13.2%Feb 2 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rt1^ who wrote (229)8/17/1997 8:49:00 PM
From: arun gera   of 3578
 
GERN valuation at the end of Friday is comparable to other cancer treatment companies with no significant revenues. I am not an expert at cancer treatment or the companies that specialize in them. This is a fairly random sample drawn from companies that are in cancer treatment business. And the other companies have not received the kind of publicity GERN got last week.

Ticker Symbol, Market cap (in millions)

IMCL, 114
AULF, 75
Alfacell, 63
SUPG, 185
QLTIF, 400
CTIC, 140
ENMD, 130
ERGO, 180

GERN's Market Cap of $140 M is in no way extraordinary!

Arun
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News